The evolution of surgical treatment for chronic leak following sleeve.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 01 06 2020
revised: 15 09 2020
accepted: 02 10 2020
pubmed: 22 11 2020
medline: 25 5 2021
entrez: 21 11 2020
Statut: ppublish

Résumé

Leak is estimated to be the most severe complication of laparoscopic sleeve gastrectomy (LSG), with sporadic failure of endoscopic techniques. In such cases, an aggressive management with surgical reconstructive procedures can be proposed to patients in whom all the conservative endoscopic techniques failed. The purpose of the present study was to report our experience with surgical approach for the treatment of chronic leak after LSG. University hospital, France. Between January 2013-December 2019, 21 consecutive patients underwent reconstructive surgery for the treatment of chronic leak after LSG. The initial intervention, the endoscopic approach, and the definitive surgical repair were carefully reviewed. Twenty-one patients (17 women) with a mean (standard deviation [SD]) age of 42.7 years (9.81) and a mean (SD) body mass index (BMI) of 27.3 (5.2) kg/m Surgery should be considered in case of failure of the endoscopic treatment of chronic leak after LSG. Further research is needed to clearly identify the appropriate treatment, but in our experience the fistulo-jejunostomy approach shows a low morbidity rate. (Surg Obes Relat Dis 2020;17:278-283.) © 2020 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Sections du résumé

BACKGROUND BACKGROUND
Leak is estimated to be the most severe complication of laparoscopic sleeve gastrectomy (LSG), with sporadic failure of endoscopic techniques. In such cases, an aggressive management with surgical reconstructive procedures can be proposed to patients in whom all the conservative endoscopic techniques failed.
OBJECTIVES OBJECTIVE
The purpose of the present study was to report our experience with surgical approach for the treatment of chronic leak after LSG.
SETTING METHODS
University hospital, France.
METHODS METHODS
Between January 2013-December 2019, 21 consecutive patients underwent reconstructive surgery for the treatment of chronic leak after LSG. The initial intervention, the endoscopic approach, and the definitive surgical repair were carefully reviewed.
RESULTS RESULTS
Twenty-one patients (17 women) with a mean (standard deviation [SD]) age of 42.7 years (9.81) and a mean (SD) body mass index (BMI) of 27.3 (5.2) kg/m
CONCLUSIONS CONCLUSIONS
Surgery should be considered in case of failure of the endoscopic treatment of chronic leak after LSG. Further research is needed to clearly identify the appropriate treatment, but in our experience the fistulo-jejunostomy approach shows a low morbidity rate. (Surg Obes Relat Dis 2020;17:278-283.) © 2020 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Identifiants

pubmed: 33218903
pii: S1550-7289(20)30598-0
doi: 10.1016/j.soard.2020.10.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

278-283

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Sulaiman Taleb (S)

CHU de Montpellier, Montpellier, France.

Marius Nedelcu (M)

ELSAN, Clinique Bouchard, Marseille, France; ELSAN, Clinique Saint Michel, Toulon, France. Electronic address: nedelcu.marius@gmail.com.

Mehdi Skalli (M)

CHU de Montpellier, Montpellier, France.

Marcelo Loureiro (M)

CHU de Montpellier, Montpellier, France; University Montpellier 1, Montpellier, France; Universidade Positivo, Curitiba, Brazil.

Anamaria Nedelcu (A)

ELSAN, Clinique Saint Michel, Toulon, France.

David Nocca (D)

CHU de Montpellier, Montpellier, France; University Montpellier 1, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH